J. Blaney

发表

B. Murphy, S. Whitehead, J. Blaney, 2007, Nature Reviews Microbiology.

Simian hemorrhagic fever virus infection of rhesus macaques as a model of viral hemorrhagic fever: clinical characterization and risk factors for severe disease.

L. Dodd, M. St. Claire, P. Jahrling, 2011, Virology.

Cowpox virus infection of cynomolgus macaques as a model of hemorrhagic smallpox.

P. Jahrling, Reed F. Johnson, J. Blaney, 2011, Virology.

Evaluation of monkeypox disease progression by molecular imaging.

D. Mollura, R. Reba, P. Jahrling, 2011, The Journal of infectious diseases.

A trade-off in replication in mosquito versus mammalian systems conferred by a point mutation in the NS4B protein of dengue virus type 4.

B. Murphy, K. Hanley, J. Blaney, 2003, Virology.

Controlled viral glycoprotein expression as a safety feature in a bivalent rabies-ebola vaccine.

P. Jahrling, J. Bernbaum, M. Schnell, 2015, Virus research.

Comparative Analysis of Monkeypox Virus Infection of Cynomolgus Macaques by the Intravenous or Intrabronchial Inoculation Route

M. St. Claire, P. Jahrling, Reed F. Johnson, 2010, Journal of Virology.

Paired Charge-to-Alanine Mutagenesis of Dengue Virus Type 4 NS5 Generates Mutants with Temperature-Sensitive, Host Range, and Mouse Attenuation Phenotypes

B. Murphy, K. Hanley, S. Whitehead, 2002, Journal of Virology.

Characterizing monkeypox virus specific CD8+ T cell epitopes in rhesus macaques

J. Sidney, A. Sette, P. Jahrling, 2013, Virology.

Immunization with a Single Major Histocompatibility Complex Class I-Restricted Cytotoxic T-Lymphocyte Recognition Epitope of Herpes Simplex Virus Type 2 Confers Protective Immunity

Y. Kawaoka, T. Fu, E. Nobusawa, 1998, Journal of Virology.

Monkeypox Virus Infection of Rhesus Macaques Induces Massive Expansion of Natural Killer Cells but Suppresses Natural Killer Cell Functions

P. Jahrling, J. Skinner, Haifeng Song, 2013, PloS one.

Antibody Quality and Protection from Lethal Ebola Virus Challenge in Nonhuman Primates Immunized with Rabies Virus Based Bivalent Vaccine

H. Feldmann, P. Jahrling, A. Marzi, 2013, PLoS pathogens.

Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2

B. Murphy, K. Hanley, S. Whitehead, 2004, BMC infectious diseases.

Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone

L. Dodd, P. Jahrling, Reed F. Johnson, 2011, Antiviral research.

Intrabronchial inoculation of cynomolgus macaques with cowpox virus.

P. Jahrling, Reed F. Johnson, J. Blaney, 2012, The Journal of general virology.

Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeys.

B. Murphy, K. Hanley, S. Whitehead, 2003, Vaccine.

Exposure of rhesus monkeys to cowpox virus Brighton Red by large-particle aerosol droplets results in an upper respiratory tract disease.

M. Lackemeyer, P. Jahrling, D. Hammoud, 2016, The Journal of general virology.

Small particle aerosol inoculation of cowpox Brighton Red in rhesus monkeys results in a severe respiratory disease.

M. Lackemeyer, P. Jahrling, D. Hammoud, 2015, Virology.

Phase 1 Trial of the Dengue Virus Type 4 Vaccine Candidate rDEN4 D 30 -4995 in Healthy Adult Volunteers

B. McKinney, M. Rock, P. Wright, 2009 .

rDEN4delta30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers.

R. Karron, B. Murphy, S. Whitehead, 2005, The Journal of infectious diseases.

Poxvirus Antigen Staining of Immune Cells as a Biomarker to Predict Disease Outcome in Monkeypox and Cowpox Virus Infection in Non-Human Primates

J. Qin, P. Jahrling, Haifeng Song, 2013, PloS one.

Systems Kinomics Demonstrates Congo Basin Monkeypox Virus Infection Selectively Modulates Host Cell Signaling Responses as Compared to West African Monkeypox Virus

P. Jahrling, B. Trost, A. Kusalik, 2011, Molecular & Cellular Proteomics.

Genetic basis of attenuation of dengue virus type 4 small plaque mutants with restricted replication in suckling mice and in SCID mice transplanted with human liver cells.

B. Murphy, J. Blaney, Joseph E Blaney, 2002, Virology.

[18F]-Fluorodeoxyglucose Uptake in Lymphoid Tissue Serves as a Predictor of Disease Outcome in the Nonhuman Primate Model of Monkeypox Virus Infection

M. St. Claire, J. Seidel, R. Reba, 2017, Journal of Virology.

Preclinical Development of Inactivated Rabies Virus-Based Polyvalent Vaccine Against Rabies and Filoviruses.

P. Jahrling, C. Wirblich, M. Schnell, 2015, The Journal of infectious diseases.

Inactivated or Live-Attenuated Bivalent Vaccines That Confer Protection against Rabies and Ebola Viruses

P. Jahrling, C. Wirblich, J. Bernbaum, 2011, Journal of Virology.

A replication-deficient rabies virus vaccine expressing Ebola virus glycoprotein is highly attenuated for neurovirulence.

P. Jahrling, C. Wirblich, M. Schnell, 2012, Virology.

Further characterization of the immune response in mice to inactivated and live rabies vaccines expressing Ebola virus glycoprotein.

P. Jahrling, C. Wirblich, M. Schnell, 2012, Vaccine.

A Live, Attenuated Dengue Virus Type 1 Vaccine Candidate with a 30-Nucleotide Deletion in the 3′ Untranslated Region Is Highly Attenuated and Immunogenic in Monkeys

B. Murphy, K. Hanley, B. Falgout, 2003, Journal of Virology.

Matched Longitudinal Analysis of Biomarkers Associated with Survival

L. Dodd, D. Follmann, Reed F. Johnson, 2014, Clinical and Vaccine Immunology.

Ebola Virus Modulates Transforming Growth Factor β Signaling and Cellular Markers of Mesenchyme-Like Transition in Hepatocytes

H. Feldmann, E. Postnikova, P. Jahrling, 2014, Journal of Virology.

Ebola Virus Modulates Transforming Growth Factor-β Signaling and Cellular Markers of 1

Anthony, H. Feldmann, E. Postnikova, 2014 .

Antiviral activity of the EB peptide against zoonotic poxviruses

P. Jahrling, J. Blaney, C. Brandt, 2012, Virology Journal.

Vaccine candidates for dengue virus type 1 (DEN1) generated by replacement of the structural genes of rDEN4 and rDEN4Δ30 with those of DEN1

B. Murphy, S. Whitehead, J. Blaney, 2007, Virology Journal.

Genetically modified, live attenuated dengue virus type 3 vaccine candidates.

B. Murphy, K. Hanley, S. Whitehead, 2004, The American journal of tropical medicine and hygiene.

Evaluation of St. Louis encephalitis virus/dengue virus type 4 antigenic chimeric viruses in mice and rhesus monkeys.

B. Murphy, A. Pletnev, S. Whitehead, 2008, Vaccine.

rDEN2/4Δ30(ME), a Live Attenuated Chimeric Dengue Serotype 2 Vaccine, is Safe and Highly Immunogenic in Healthy Dengue-Naïve Adults

B. Murphy, J. Blaney, A. Durbin, 2006, Human vaccines.

Development of a live attenuated dengue virus vaccine using reverse genetics.

B. Murphy, S. Whitehead, J. Blaney, 2006, Viral immunology.

Mutations which enhance the replication of dengue virus type 4 and an antigenic chimeric dengue virus type 2/4 vaccine candidate in Vero cells.

B. Murphy, J. Blaney, Daniel H. Johnson, 2003, Vaccine.

rDEN4Δ30, a Live Attenuated Dengue Virus Type 4 Vaccine Candidate, Is Safe, Immunogenic, and Highly Infectious in Healthy Adult Volunteers

R. Karron, B. Murphy, B. Murphy, 2005 .

A Single Dose of the DENV-1 Candidate Vaccine rDEN1Δ30 Is Strongly Immunogenic and Induces Resistance to a Second Dose in a Randomized Trial

B. Murphy, S. Whitehead, J. Blaney, 2011, PLoS neglected tropical diseases.

Phase 1 trial of the dengue virus type 4 vaccine candidate rDEN4{Delta}30-4995 in healthy adult volunteers.

B. McKinney, B. Murphy, M. Rock, 2009, The American journal of tropical medicine and hygiene.

Phase I clinical evaluation of rDEN4Delta30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity.

B. Murphy, J. Blaney, A. Durbin, 2008, The American journal of tropical medicine and hygiene.

Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3' untranslated region (3'-UTR) or by exchange of the DENV-3 3'-UTR with that of DENV-4.

B. Murphy, K. Hanley, Laura B. Goddard, 2008, Vaccine.

Targeted mutagenesis as a rational approach to dengue virus vaccine development.

B. Murphy, S. Whitehead, J. Blaney, 2010, Current topics in microbiology and immunology.

Phase 1 Trial of the Dengue Virus Type 4 Vaccine Candidate rDEN4D30 -4995 in Healthy Adult Volunteers

B. McKinney, B. Murphy, M. Rock, 2009 .

Introduction of mutations into the non-structural genes or 3' untranslated region of an attenuated dengue virus type 4 vaccine candidate further decreases replication in rhesus monkeys while retaining protective immunity.

B. Murphy, K. Hanley, S. Whitehead, 2004, Vaccine.

Chemical Mutagenesis of Dengue Virus Type 4 Yields Mutant Viruses Which Are Temperature Sensitive in Vero Cells or Human Liver Cells and Attenuated in Mice

B. Murphy, S. Whitehead, J. Blaney, 2001, Journal of Virology.

Human Liver Cells and Attenuated in Mice Temperature Sensitive in Vero Cells or Type 4 Yields Mutant Viruses Which Are Chemical Mutagenesis of Dengue Virus

B. Murphy, S. Whitehead, J. Blaney, 2001 .

Recombinant, Live-Attenuated Tetravalent Dengue Virus Vaccine Formulations Induce a Balanced, Broad, and Protective Neutralizing Antibody Response against Each of the Four Serotypes in Rhesus Monkeys

Brian R. Murphy, B. Murphy, S. Whitehead, 2005, Journal of Virology.

The effect of volume of interest definition on quantification of lymph node immune response to a monkeypox virus infection assessed by 18F-FDG-PET

J. Seidel, R. Reba, P. Jahrling, 2014, EJNMMI Research.

Differential effects of IκB molecules on tat-mediated transactivation of HIV-1 LTR

E. Harhaj, Shao-Cong Sun, J. Blaney, 1996 .

Arguments for live flavivirus vaccines

B. Murphy, S. Whitehead, J. Blaney, 2004, The Lancet.

Temperature sensitive mutations in the genes encoding the NS1, NS2A, NS3, and NS5 nonstructural proteins of dengue virus type 4 restrict replication in the brains of mice

B. Murphy, S. Whitehead, J. Blaney, 2003, Archives of Virology.